Seroprevalence of Hepatitis B surface antigen in a tertiary care setting in Maharashtra, India: clinical and public health impact
IMC Journal of Medical Science · 11.05.2026 · 1
DOI: 10.55010/imcjms.20.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift IMC Journal of Medical Science, online erschienen am 11.05.2026. Verfasst von Sabiha Tamboli und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background and objectives: Hepatitis B virus (HBV) infection remains one of the most significant global health challenges, with an estimated 296 million chronically infected individuals worldwide. Hepatitis B surface antigen (HBsAg) detection is a cornerstone in the serological diagnosis of HBV, serving as a marker for both acute and chronic infection. Despite the availability of advanced diagnostic techniques such as enzyme-linked immunosorbent assay (ELISA) and chemiluminescent immunoassay (CLIA), rapid immunochromatographic tests (ICTs) are widely used in resource-limited healthcare settings for their affordability and simplicity. The present study aimed to determine the seroprevalence of HBsAg among patients attending a tertiary care hospital over six months, analyse the distribution of infection across age and gender and compare findings with other studies. Materials and methods: A hospital-based cross-sectional study was conducted in the Department of Microbiology, from January 2025 to June 2025. A total of 3,200 serum samples were screened for HBsAg using rapid ICT kits. (Erba HBsAg Rapid test Manufacturer’s name Transasia Biomedicals Ltd, Mumbai Maharashtra India). Data were analysed by age, gender, and monthly trends. Results: Out of 3,200 samples screened, 53 tested positive, yielding an overall prevalence of 1.65%. The highest positivity was observed in patients >60 years (4.54%), followed by the 41-60 years age group (2.58%). No positive cases were detected among children
Zitieren
APA
Tamboli, S., & Yelikar, K. (2026). Seroprevalence of Hepatitis B surface antigen in a tertiary care setting in Maharashtra, India: clinical and public health impact. IMC Journal of Medical Science, 1. https://doi.org/10.55010/imcjms.20.007
Vancouver
Tamboli S, Yelikar K. Seroprevalence of Hepatitis B surface antigen in a tertiary care setting in Maharashtra, India: clinical and public health impact. IMC Journal of Medical Science. 2026:1. doi:10.55010/imcjms.20.007
BibTeX
@article{Tamboli2026,
author = {Tamboli, Sabiha and Yelikar, Kananbala},
title = {Seroprevalence of Hepatitis B surface antigen in a tertiary care setting in Maharashtra, India: clinical and public health impact},
journal = {IMC Journal of Medical Science},
year = {2026},
pages = {1},
doi = {10.55010/imcjms.20.007}
}
EUVIMED